Objectives: To identify the prevalence and associated factors of psychiatric morbidities and to evaluate the effectiveness of the Hospital Anxiety and Depression Scale (HADS) in screening for psychiatric morbidity in patients with knee osteoarthritis in a local orthopaedic clinic.
Methods: A cross-sectional study was conducted from October 2013 to June 2014 to examine patients with knee osteoarthritis at a specialist orthopaedic clinic. They were evaluated for psychiatric diagnoses using the Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID-I). Socio-demographic and clinical characteristics were compared between patients with and without psychiatric morbidity. Patients were also assessed using the HADS with accuracy compared with the psychiatric diagnoses made by the SCID-I.
Results: Of the 115 patients, 39% had current psychiatric disorders. Logistic regression analysis revealed that limitation of physical activity, perceived absence of confidant, a history of psychiatric illness, and follow-up in orthopaedic clinic for ≥ 5 years were independent factors associated with psychiatric disorders.
Conclusions: The prevalence of psychiatric morbidity in patients with knee osteoarthritis was significant. Recognition of independent associated factors can aid in early identification and intervention in patients who are at risk of developing psychiatric morbidity. The HADS is a useful means to screen for psychiatric morbidity in these patients.
Download full-text PDF |
Source |
---|
World Cult Psychiatry Res Rev
January 2023
Columbia University Vagelos College of Physicians and Surgeons, Department of Psychiatry, New York, USA.
We evaluated the 5-item Psychosis Screening Questionnaire (PSQ) against a diagnostic gold standard in South Africa. 1885 adults at primary and tertiary health facilities were screened with the PSQ and diagnosed using the Mini International Neuropsychiatric Interview-V. Minor adaptations were required of both instruments to distinguish between psychiatric symptoms and normative cultural beliefs.
View Article and Find Full Text PDFObjective: Our objective of this study was to analyse all oncological clinical trials using regorafenib to create a complete risk/benefit profile for the drug.
Background: Creating a novel chemotherapy is costly both in time and capital spent for drug manufacturers. To regenerate what they've spent, drug manufacturers may attempt to repurpose their medications for new indications via clinical trials.
Sleep Epidemiol
December 2024
Cochlear Center for Hearing and Public Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Background: Population-based evidence linking sleep characteristics with hearing is limited and how the associations change with age remains unknown. We aim to investigate cross-sectional associations between sleep characteristics and hearing by age in a nationally representative sample of U.S.
View Article and Find Full Text PDFDigit Health
January 2025
Secretaria do Estado de Educação do Distrito Federal, Escola Técnica de Ceilândia, Educação à Distância. Distrito Federal, Brazil.
Objective: Promoting healthy lifestyle behaviors is essential for preventing and managing chronic and mental health conditions. This study aims to present a digital health platform accessible via PC or smartphone, , designed to foster lifestyle change among the Brazilian population. It evaluates interest, uptake, acceptability, usability, adherence, and retention over 12 weeks.
View Article and Find Full Text PDFAust N Z J Psychiatry
February 2025
Telethon Kids Institute, Perth, WA, Australia.
Objectives: The burden of perinatal mental illness is a significant global concern, affecting approximately 10-20% of women at this stage of life. It is well recognised that Rural Australia has far less health services and mental health specialists per capita than metropolitan regions. While women have more babies in rural settings, their access to maternal health care is conversely limited or absent.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!